Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

OUCRU Outbreak Advisory Board in the COVID-19 Pandemic in Viet Nam

Ngo PBT. et al, (2024), Wellcome Open Research, 9, 422 - 422

Antimicrobial resistance among common bacterial pathogens in Indonesia: a systematic review

Gach MW. et al, (2024), The Lancet Regional Health - Southeast Asia, 26, 100414 - 100414

Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-CoV-2 in Vietnam.

Trang NT. et al, (2024), Sci Rep, 14

Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2024)

Clinical presentation and treatment of 2 patients with infection caused by Chromobacterium violaceum in Vietnam.

Nam BV. et al, (2024), BMC Infect Dis, 24

Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in the Laos

Chansamouth V. et al, (2024), Wellcome Open Research, 9, 183 - 183

Antibiotic prescribing practices of medical doctors in a resource-limited setting and the influence of individual perceptions and stewardship support: a survey in three tertiary hospitals in Vietnam.

Vu HTL. et al, (2024), JAC Antimicrob Resist, 6

Age-time-specific transmission of hand-foot-and-mouth disease enterovirus serotypes in Vietnam: A catalytic model with maternal immunity.

Chen Y. et al, (2024), Epidemics, 46

Barriers and enablers to blood culture sampling in Indonesia, Thailand and Viet Nam: a Theoretical Domains Framework-based survey.

Suntornsut P. et al, (2024), BMJ Open, 14

Feasibility of wearable monitors to detect heart rate variability in children with hand, foot and mouth disease.

Nhan LNT. et al, (2024), BMC Infect Dis, 24

Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023.

Chau NVV. et al, (2024), Emerg Infect Dis, 30, 363 - 367

Implementing the WHO AWaRe antibiotic book guidance in lower-resource settings: the case of the Lao PDR.

Chansamouth V. et al, (2024), JAC Antimicrob Resist, 6

Understanding hospital antimicrobial prescribing decisions and determinants of uptake of new local antimicrobial prescribing guidelines in Laos.

Chansamouth V. et al, (2024), Wellcome Open Res, 9

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2023), Lancet Diabetes Endocrinol, 11, 905 - 914

Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.

Baker KS. et al, (2023), Lancet Microbe, 4, e1035 - e1039

Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces.

Muloi DM. et al, (2023), Lancet Microbe, 4, e1056 - e1062

Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities.

Jauneikaite E. et al, (2023), Lancet Microbe, 4, e1040 - e1046

Genomics for public health and international surveillance of antimicrobial resistance.

Baker KS. et al, (2023), Lancet Microbe, 4, e1047 - e1055

Innovations in genomic antimicrobial resistance surveillance.

Wheeler NE. et al, (2023), Lancet Microbe, 4, e1063 - e1070

Talaromycosis

Le T. et al, (2023), Diagnosis and Treatment of Fungal Infections: Third Edition, 339 - 349

Load More

Include forthcoming?